Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Small intestinal release peppermint oil is an enteric-coated formulation of peppermint oil designed to release its contents in the small intestine. The main active constituent is L-menthol, which exerts a dose-related antispasmodic effect on gastrointestinal smooth muscle by inhibiting calcium influx into smooth muscle cells[7]. This formulation is primarily used to treat symptoms of irritable bowel syndrome (IBS), including abdominal pain, bloating, gas, and diarrhea[2][4]. The enteric coating prevents premature release in the stomach, which can cause heartburn and indigestion, ensuring the active ingredients reach the small intestine where they can act directly on intestinal smooth muscle[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on small intestinal release peppermint oil.